LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

3D-Printed Heart Valve Models Mimic Physiology

By LabMedica International staff writers
Posted on 17 Jul 2017
Image: New 3D printing technologies allow researchers to create patient-specific heart valve models that mimic the physiological qualities of the real valves. This image shows the submerged valve during flow testing (Photo courtesy of the Georgia Institute of Technology).
Image: New 3D printing technologies allow researchers to create patient-specific heart valve models that mimic the physiological qualities of the real valves. This image shows the submerged valve during flow testing (Photo courtesy of the Georgia Institute of Technology).
Cardiovascular disease researchers used an advanced multi-material three-dimensional printing technique to create patient-specific heart valve models that mimic the physiological qualities of human valves.

Investigators at the Georgia Institute of Technology (Atlanta, USA) had shown previously that a metamaterial three-dimensional printing technique could be used to create patient-specific phantoms that mimicked the mechanical properties of biological tissue. In the current study, they aimed to use this methodology to develop a procedure simulation platform for in vitro transcatheter aortic valve replacement (TAVR). In addition, they evaluated the feasibility of using these three-dimensional printed mimics to quantitatively predict the occurrence, severity, and location of any degree of post-TAVR paravalvular leaks (PVL).

In conducting this retrospective study involving 18 patients who had undergone TAVR, patient-specific aortic root mimics were created using the three-dimensional printing technique combined with pre-TAVR computed tomography. CoreValve (self-expanding valve) prostheses were deployed in the mimics to simulate the TAVR procedure, from which post-TAVR aortic root strain was quantified in vitro. A novel index, the annular bulge index, was measured to assess the post-TAVR annular strain unevenness in the mimics.

Results published in the July 7, 2017, online edition of the journal JACC: Cardiovascular Imaging revealed that the maximum annular bulge index was significantly different among patient subgroups that had no PVL, trace-to-mild PVL, and moderate-to-severe PVL. Compared with other known PVL predictors, bulge index was the only significant predictor of moderate-severe PVL. Thus, in this proof-of-concept study, the investigators demonstrated the feasibility of using three-dimensional printed tissue-mimics to quantitatively assess post-TAVR aortic root strain in vitro.

"These three-dimensional printed valves have the potential to make a huge impact on patient care going forward," said contributing author Dr. Chuck Zhang, professor of industrial and systems engineering at the Georgia Institute of Technology. "Previous methods of using three-dimensional printers and a single material to create human organ models were limited to the physiological properties of the material used. Our method of creating these models using metamaterial design and multi-material three-dimensional printing takes into account the mechanical behavior of the heart valves, mimicking the natural strain-stiffening behavior of soft tissues that comes from the interaction between elastin and collagen, two proteins found in heart valves."

Related Links:
Georgia Institute of Technology

Gold Member
Immunochromatographic Assay
CRYPTO Cassette
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gel Cards
DG Gel Cards
Silver Member
PCR Plates
Diamond Shell PCR Plates

Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more